Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Postherpetic Neuralgia
IRCT20180404039187N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in postherpetic neuralgia (PHN), sponsored by Tabriz University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
memantine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on IRCT20180404039187N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039187N6.